S-11C-methyl-L-cysteine: A new amino acid PET tracer for cancer imaging

Journal of Nuclear Medicine

Volumn 52, Issue 2, 2011, Pages 287-293

  Deng, Huaifu ^a   Tang, Xiaolan ^b   Wang, Hongliang ^a   Tang, Ganghua ^a   Wen, Fuhua ^a   Shi, Xinchong ^a   Yi, Chang ^a   Wu, Kening ^a   Meng, Quanfei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

11CH3I; Amino acid; Inflammation; PET imaging; S 11C methyl L cysteine; Tumor

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; S METHYLCYSTEINE; S METHYLCYSTEINE C 11; UNCLASSIFIED DRUG; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PROTEIN; RADIOPHARMACEUTICAL AGENT; S-METHYLCYSTEINE; TRACER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; CANCER RECURRENCE; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG DISTRIBUTION; DRUG PURITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ENANTIOMER; FALSE NEGATIVE RESULT; FEMALE; GLIOMA; HEPATOMA CELL; HUMAN; INFLAMMATION; LIVER CELL CARCINOMA; MALE; METHYLATION; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TUMOR CELL LINE; ACTIVE TRANSPORT; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; METABOLISM; NEOPLASM; NUDE MOUSE; QUALITY CONTROL; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; FEMALE; ISOTOPE LABELING; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROTEINS; QUALITY CONTROL; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 79851505103     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.081349     Document Type: Article

References (30)

1. Tang GH. Positron emission tomography imaging and drug development. Acta Pharmacol Sin. 2001;36:470-474.
2. 18F-fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 1999;40: 1367-1373.
3. Laverman P, Boerman OC, Corstens FHM, Oyen WJG. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging. 2002;29:681-690. (Pubitemid 34439330)
4. Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med. 2001;15:471-486. (Pubitemid 34131944)
5. Sasaki M, Kuwabara Y, Yoshida T, et al. Comparison of MET-PET and FDGPET for differentiation between benign lesions and malignant tumors of the lung. Ann Nucl Med. 2001;15:425-431. (Pubitemid 33111299)
6. 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med. 2000;41:283-290.
7. Maeda Y, Oguni H, Saitou Y, et al. Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings. Epilepsia. 2003;44:1118-1121. (Pubitemid 36959321)
8. 11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med. 1988;29:1419-1427.
9. 18F-FLT for differentiation between tumor and inflammation in rats. Nucl Med Biol. 2009;36:681-686.
10. 18F]fluoroethyl)-l-tyrosine. Appl Radiat Isot. 2002;57:853-856.
11. 11C]methylation on C18 Sep-Pak. J Labelled Comp Radiopharm. 1999;42:715-724.
12. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301-1306.
13. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
14. 11C] methylation. Nucl Technol. 2004;26:77-83.
15. 18F]-fluoro-2-deoxy-D-glucose. Nucl Technol. 2006;29:531-536.
16. Langen KJ, Jarosch M, Muhlensiepen H, et al. Comparison of fluorotyrosine and methionine uptake in F98 rat gliomas. Nucl Med Biol. 2003;30:501-508. (Pubitemid 36776519)
17. 18F]fluoro-L-proline in F98 gliomas cells. Nucl Med Biol. 2002;29:685-692.
18. 11C-CYS as an oncologic PET tracer [abstract]. J Nucl Med. 2010;51(suppl 2):102P.
19. Wassef R, Haenold R, Hansel A, Brot N, Heinemann SH, Hoshi1 T. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms. J Neurosci. 2007;27:12808-12816. (Pubitemid 350159591)
20. Yeh YY, Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr. 2001;131:989S-993S.
21. Hsu CC, Huang CN, Hung YC, Yin MC. Five cysteine-containing compounds have antioxidative activity in Balb/cA mice. J Nutr. 2004;134:149-152.
22. Jager PL, Vaalburg W, Prium J, de Vries EGE, Langen KJ, Piers DA. Radio-labeled amino acid: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432-445. (Pubitemid 32207394)
23. 18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
24. Tovar AR, Tews JK, Torres N, Harper AE. Neutral amino acid transport into rat skeletal muscle: competition, adaptive regulation, and effects of insulin. Metabolism. 1991;40:410-419.
25. 11C]methionine in adult humans. Proc Natl Acad Sci USA. 1998;95:12793-12798.
26. McConathy J, Goodman MM. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev. 2008;27:555-573.
27. 18F-fluoro-Ldopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med. 2007;48:2063-2071.
28. 11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas. J Neurooncol. 2010;99:217-225.
29. Fuchs BC, Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 2005;15:254-266.
30. 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging. 2002;29:648-654.